The Priapus Shot,® (also known as the P-shot) is designed to deliver lasting improvements in sexual performance to men, especially those who have lost function due to an enlarged prostate, prostate cancer, the after-effects of surgery, drug side effects and other conditions such as diabetes. The Priapus Shot® procedure begins with a quick and easy blood draw. Then, using a proprietary technique, the growth factors are extracted from your blood and concentrated into the Platelet Rich Plasma (PRP). PRP is the injected into areas of the penis that are most important for the sexual response. These areas are numbed with a local anesthetic cream before injection, yielding little or no discomfort during the procedure. Platelet Rich Plasma contains many growth factors and healing factors. PRP has regenerative abilities and thus stimulates healing and rejuvenation. The resulting benefits typically include tissue growth that increases growth of new blood vessels and improved circulation within the penis, stronger erections, increased sensation and pleasure and enhanced sexual performance. Some men report changes in girth and length of the penis. Many of these benefits are experienced immediately after receiving the injection. And, because the treatment uses the patient’s own blood derived plasma, it is non-allergenic and free of harmful side effects. We have acquired the latest evidence based device to treat men with ED with an 80% success rate!
What is shockwave therapy and how might it help men with erectile dysfunction?
Erectile Dysfunction Shock Wave Therapy (EDSWT) is an innovative approach to treat vasculogenic ED, delivered by our Shockwave Therapy device that uses advanced acoustics technology. EDSWT applies low-intensity extracorporeal (outside the body) shock waves to the tissue. Extracorporeal Shock Waves to the penile tissue, improve the blood flow to the penis. Vasculogenic and diabetic ED patients (no hormonal, neurologic or psychological causes), who are responsive to PDE5 inhibitors as well as those who are unresponsive, can receive shock wave therapy from the device and experience improved erectile function.
Our EXCLUSIVE TAM Shockwave Therapy Treatment Plan which includes The P-shot has the highest success rate.
Shockwave therapy uses energy from acoustic waves to trigger a process called neovascularization in certain parts of the body. When neovascularization occurs, new blood vessels form. This helps improve blood flow to the region. This type of therapy has been used to help heart patients, people with kidney stones, and those with fractures and joint inflammation. Recently, scientists have investigated low-intensity shockwave therapy to help men with erectile dysfunction (ED). Our Shockwave Therapy system is a multi-application device that can be used for additional indications. Switching from treating one clinical indication to another, can now be done in a user-friendly, straightforward manner, by simply replacing the designated shock wave applicator; Once the system detects a specific applicator, the relevant software and application are launched.
Urological Indications – Prostatitis (CPPS) Peyronie’s disease Vascular Indications /Erectile Dysfunction – Peripheral Artery Disease and Chronic Limb Ischemia associated with intermittent claudication Diabetic foot ulcers and neuropathy Wound healing – acute and chronic wounds
Clinical trials of shockwave therapy for ED have had amazing results. The process has been well tolerated by patients. Many men have found that their erections have improved and they are able to have intercourse, and report waking up with an erection again .Some Men with more severe ED may still need to take ED medication in addition to having shockwave therapy.
Remember, we stand by our treatments and results!
Blood flow is critical to a man’s erections. When a man is sexually stimulated, arteries widen so that his penis can fill with blood. The blood is what gives the penis the firmness needed for vaginal penetration. A man who has problems with blood flow to the penis may have weaker erection or may be unable to have an erection at all. There are several types of treatments available to men with ED, including pills, vacuum erection devices, and penile injections. However, these therapies are typically conducted on an as-needed basis and may work for only one sexual encounter at a time. Shockwave therapy is different, as it targets the erectile mechanism so that men are more likely to have erections on their own. When we administer shockwave therapy, The Doctor applies a probe to the penis, which is coated in a special gel. Different areas of the penis are usually targeted. Treatment sessions may last for fifteen to twenty minutes. Men usually don’t need anesthesia or experience pain, although they might have a tingling sensation in the treated area.
One will not be eligible for ESWT if he has one or more of the following conditions:Any cause of ED other than vascular Penile tumor Prostate tumor Testicle tumor Local tumor at the treatment area
EDSWT was officially accepted by the European Association of Urology (EAU) as the gold standard for treatment of Erectile Dysfunction in the EAU 2013 guidelines on Male Sexual Dysfunction. This was based on clinical trials using this specialized device. No need to suffer anymore. We just need recent bloodwork and PSA from your primary Doctor. Let us know next best steps for you.
Research LinksLow-Intensity Extracorporeal Shock Wave Therapy for ErectileDysfunction: a Systematic Review and Meta-Analysis. Man L, Li G.
Urology. 2017 Sep 26. pii: S0090-4295(17)30992-5. doi: 10.1016/j.urology.2017.09.011. [Epub ahead of print]Low-Intensity Extracorporeal Shockwave Therapy Can Improve Erectile Function in Patients Who Failed to Respond to Phosphodiesterase Type 5 Inhibitors.
Tsai CC, Wang CJ, Lee YC, Kuo YT, Lin HH, Li CC, Wu WJ, Liu CC. Am J Mens Health. 2017 Nov;11(6):1781-1790. doi: 10.1177/1557988317721643. Epub 2017 Sep 8.Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial.
Kalyvianakis D, Hatzichristou D. J Sex Med. 2017 Jul;14(7):891-897. doi: 10.1016/j.jsxm.2017.05.012. Erratum in: J Sex Med. 2018 Feb;15(2):270.In Situ Activation of Penile Progenitor Cells With Low-Intensity Extracorporeal Shockwave Therapy.
Lin G, Reed-Maldonado AB, Wang B, Lee YC, Zhou J, Lu Z, Wang G, Banie L, Lue TF. J Sex Med. 2017 Apr;14(4):493-501. doi: 10.1016/j.jsxm.2017.02.004. Epub